Natalia Elizalde PhD, Chief Business Development Officer, VIVEbiotech explores how the lentiviral vector specialists are bridging the gap between R&D and commercialisation.
Agnes Cwienczek, ALSS Head of Product Management and Consulting, ArisGlobal discusses the benefits of acting now to reap the benefits of eCTD 4.0 compliance.
Jinhyeok Jeong and John Thomas, Senior Directors of DP Inspection & Packaging and DP MSAT, explores the major areas of DP manufacturing that can accelerate timelines from development to commercialisation.
Brian Eastwood, Global Head of Business Development, Almac Pharma Services, and Simon Hamilton, Head of Global Business Development, Almac Sciences explore the benefits of a single source provider for development through to commercialisation.
Catherine Wilkes, Executive Director of Environmental, Health and Safety at Quotient Sciences explores how containment protocols shift when dealing with HPAPIs to meet the required safety standards.
François Rieger, CEO, and Carole Nicco, Chief Scientific Officer, BioSenic, looks at the use of Arsenic as a novel API as a companion piece to our latest EPM Issue.
In our latest EPM Magazine Issue, Christiane Schuler, Communication Manager, at Siemens explores the role Siemens played in helping create one of the world's premier pharma production facilities.
Greater awareness and increasing popularity among consumers to select drugs or food supplements exhibiting a clean label is a trend that producers are unable to ignore. The IMA Active laboratory explores...
Jerry Temko, Managing Director, In-House Counsel Group, Major, Lindsey & Africa explores how Life science companies are becoming more alive to the role that in-house legal teams will play in safely and successfully taking on the AI challenge.
Pete Lomas, Managing Consultant at Broughton, a scientific consultancy and contract research organisation, discusses how manufacturers can design vapes to improve their chances of MAA approval.
